Updated
Cue BiopharmaCUE · Healthcare
$19.95-0.94%
Market cap$104M
IndustryBiotechnology
Cue Biopharma (CUE) Superinvestor holders
2 of the superinvestors we track hold Cue Biopharma (CUE) in their latest 13F filings, $2M in total.
Summary
The largest holder is Didric Cederholm (Lion Point Capital), with $2M, 8.0% of the portfolio.
In their latest quarter: 2 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| Didric Cederholm Lion Point Capital |
Trimmed | 52,928 | $2M | 8.0% | Q2 2026 |
| Jim Simons Renaissance Technologies |
Trimmed | 14,689 | $463,585 | 0.0% | Q2 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 2 |
| Q1 2026 | 2 |
| Q4 2025 | 2 |
| Q3 2025 | 1 |
| Q2 2025 | 1 |
| Q1 2025 | 1 |
| Q1 2024 | 4 |
| Q4 2023 | 3 |
Questions about Cue Biopharma
Which superinvestors own Cue Biopharma?
2 of the superinvestors we track hold Cue Biopharma (CUE) in their latest 13F filings, $2M in total. Didric Cederholm, Jim Simons.
Who is the largest superinvestor holder of CUE?
The largest holder is Didric Cederholm (Lion Point Capital), with $2M, 8.0% of the portfolio.
From Cue Biopharma's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.